Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the
industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance
debt, including our ability to obtain the
debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign
current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
And its
current debt - to - Ebitda ratio of 2.6, below the
industry average, suggests that it has more flexibility to withstand sustained low prices than many of its competitors.
After all, even if the door closes on the
current debt - settlement model — if the
industry's history is anything to go by — another is bound to open.
It's the financial
industry's playbook to assess your
current financial situation, build a budget, cut expenses, pay down
debt, create «saving for retirement» goals, and prepare for the unexpected.
Commercial
debt financing is essentially nonexistent in the
current marketplace, so in order for this
industry to scale, a mix of sources will need to be developed in the next 18 months.
We look at factors such as
current and historical EPS and FCF payout ratios,
debt levels, free cash flow generation,
industry cyclicality, ROIC trends, and more.
He frequently speaks to
industry leaders at conferences around the world on the
current state of the global
debt markets.
I think this has a lot to do with the
current uncertainty with my job in the oil
industry, but I also think it has to do with finally appreciating what it actually feels like to be
debt free.
As we have written in prior posts, the CFPB exists largely because the lending
industry (including many
current private student lenders) engaged in widespread predatory practices that buried many consumers in
debt.
The 2nd panel covered the following topic, «The For - Profit
Debt Settlement
Industry Today: Perspectives on
Current Industry Trends and Practices».
The second major protective factor is the company's fortress - like balance, specifically one marked by an enormous net cash position (enough to fund the dividend for 18 years), and one of the highest
current ratios (short - term assets / short - term liabilities) in the
industry, indicating the company has no problems servicing its
debt or liabilities.
This panel discussion will outline the
current trends in the
debt settlement
industry and provide an update on legislative and regulatory proposals which may impact the
industry going forward.
In light of the
current state of student
debt, there is a perception in the
industry that newer veterinarians do not want to pursue practice ownership.
As an introduction, Colon cited the
current conditions in the equine veterinary field: high levels of educational
debt, untenable
debt - to - income ratios and an equine
industry with little to no growth.
Mr Cram, an expert on net lease financing and investment, and a frequent guest at
industry conferences worldwide, participated in a roundtable discussion on
current trends in medical care in retail environments, and was a panelist in a breakout session on capital markets — offering his views on the outlook for
debt financing in the coming year.